Clinical Trial Update: Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism [Phase 4]

View source ↗

Summary

Phase 4 trial update examining milnacipran for autism spectrum disorders, including functional locus coeruleus and noradrenergic pathway considerations; study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asperger Syndrome
• Autism Spectrum Disorder

Drugs mentioned

• Milnacipran (milnacipran)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Autism Spectrum Disorder, Asperger Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2020-02-27